Literature DB >> 12417342

Expression and regulation of peroxiredoxin 5 in human osteoarthritis.

Min Xia Wang1, Aiqun Wei, Jun Yuan, Annette Trickett, Bernard Knoops, George A C Murrell.   

Abstract

Reactive oxygen species (ROS) are implicated in the pathogenesis of osteoarthritis (OA). However, little is known about the antioxidant defence system in articular cartilage. We investigated the expression and regulation of peroxiredoxin 5 (PRDX5), a newly discovered thioredoxin peroxidase, in human normal and osteoarthritic cartilage. Our results show that human cartilage constitutively expresses PRDX5. Moreover, the expression is up-regulated in OA. Inflammatory cytokines tumour necrosis factor alpha and interleukin 1 beta contribute to this up-regulation by increasing intracellular ROS production. The present study suggests that PRDX5 may play a protective role against oxidative stress in human cartilage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417342     DOI: 10.1016/s0014-5793(02)03511-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage.

Authors:  Ann K Rosenthal; Claudia M Gohr; James Ninomiya; Bassam T Wakim
Journal:  Arthritis Rheum       Date:  2011-02

2.  Analyses of differential proteome of human synovial fibroblasts obtained from arthritis.

Authors:  Gan-Ping Bo; Li-Na Zhou; Wei-Feng He; Gao-Xing Luo; Xiong-Fei Jia; Cheng-Jun Gan; Guang-Xing Chen; Yong-Fei Fang; Peter Mose Larsen; Jun Wu
Journal:  Clin Rheumatol       Date:  2008-09-20       Impact factor: 2.980

3.  Identification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysis.

Authors:  Bing Yan; Jie Li; Li Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.

Authors:  Lynn Petukhova; Madeleine Duvic; Maria Hordinsky; David Norris; Vera Price; Yutaka Shimomura; Hyunmi Kim; Pallavi Singh; Annette Lee; Wei V Chen; Katja C Meyer; Ralf Paus; Colin A B Jahoda; Christopher I Amos; Peter K Gregersen; Angela M Christiano
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

5.  Comparative study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's disease.

Authors:  Hong Gao; Xiaomei Liu; Dong Chen; Liangying Lv; Mei Wu; Jie Mi; Weilin Wang
Journal:  Int J Exp Pathol       Date:  2014-04-29       Impact factor: 1.925

6.  Inhibition of cyclooxygenases by dipyrone.

Authors:  S C Pierre; R Schmidt; C Brenneis; M Michaelis; G Geisslinger; K Scholich
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

Review 7.  The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Authors:  Gabriella Pietra; Chiara Romagnani; Claudia Manzini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  J Biomed Biotechnol       Date:  2010-06-22

8.  Molecular cloning, characterization and mRNA expression of peroxiredoxin in Zhikong scallop Chlamys farreri.

Authors:  Ming Cong; Duojiao Ni; Linsheng Song; Lingling Wang; Jianmin Zhao; Limei Qiu; Ling Li
Journal:  Mol Biol Rep       Date:  2008-08-14       Impact factor: 2.316

Review 9.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

10.  Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes.

Authors:  Katalin É Szabó-Taylor; Paul Eggleton; Carly A L Turner; M Letizia Lo Faro; Joanna M Tarr; Sára Tóth; Matt Whiteman; Richard C Haigh; Jennifer A Littlechild; Paul G Winyard
Journal:  Int J Biochem Cell Biol       Date:  2012-04-28       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.